<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A <z:e sem="disease" ids="C1705254" disease_type="Disease or Syndrome" abbrv="">congenital malformations</z:e> surveillance program in effect at the Ruiz y Páez Hospital in Ciudad Bolívar since April 1978, has allowed us to detect 25 patients with <z:e sem="disease" ids="C0029422" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">osteochondrodysplasias</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCD</z:e>) in a total of 70,152 newborns, up to August 1990, for a prevalence of one case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">OCD</z:e> every 2,806 newborns </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical entities found were: <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e>, Thanatophoric <z:mpath ids='MPATH_589'>Dysplasia</z:mpath>, <z:e sem="disease" ids="C0029434" disease_type="Disease or Syndrome" abbrv="">Osteogenesis Imperfecta</z:e> II-A, Camptomelic <z:mpath ids='MPATH_589'>Dysplasia</z:mpath>, Kniest <z:mpath ids='MPATH_589'>Dysplasia</z:mpath>, <z:e sem="disease" ids="C0282102" disease_type="Disease or Syndrome" abbrv="CDPX2|CDPXD">Conradi</z:e>-Hunnerman syndrome, Parenti-Fracaro type Achondrogenesis and <z:e sem="disease" ids="C0265275" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Jeune</z:e> Asphyxiating <z:hpo ids='HP_0006644'>Thoracic Dysplasia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The results presented in this paper indicate that this type of diseases represent a relatively important group of nosological entities adding up to more than 200 new annual cases in the country </plain></SENT>
<SENT sid="3" pm="."><plain>This relatively high frequency, the different <z:hpo ids='HP_0000005'>inheritance</z:hpo> mechanisms involved, the variable complications and the high morbidity and mortality rate of these diseases, make the patients affected, a problematic group not receiving, in general, adequate medical attention regarding diagnosis, genetic counselling and treatment </plain></SENT>
</text></document>